Work

Safety and Tolerability of Crofelemer 125 Mg Twice Daily in the Treatment of Noninfectious Diarrhea in Hiv-seropositive Patients on Antiretroviral Therapy: Results From a Phase 3, 48-week Open-label Study

Year: 2014

Type: article

Source: Digital Commons @ UNT Health Science Center

Author: Clay, Patrick G

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1547852343

FWCI:

Cites:

Cited by: 1

Related to: 10